GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » LT-Debt-to-Total-Asset

Jacobio Pharmaceuticals Group Co (HKSE:01167) LT-Debt-to-Total-Asset : 0.09 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Jacobio Pharmaceuticals Group Co's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.09.

Jacobio Pharmaceuticals Group Co's long-term debt to total assets ratio increased from Jun. 2023 (0.08) to Jun. 2024 (0.09). It may suggest that Jacobio Pharmaceuticals Group Co is progressively becoming more dependent on debt to grow their business.

Jacobio Pharmaceuticals Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co LT-Debt-to-Total-Asset Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial - - 0.09 0.08 0.06

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.08 0.09 0.06

Jacobio Pharmaceuticals Group Co LT-Debt-to-Total-Asset Calculation

Jacobio Pharmaceuticals Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=133.407/1597.443
=0.08

Jacobio Pharmaceuticals Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )/Total Assets (Q: Jun. 2024 )
=128.85/1413.245
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co  (HKSE:01167) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Jacobio Pharmaceuticals Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
HKSE:02509 HKSE:02137 HKSE:02487 HKSE:02566 HKSE:01875 HKSE:06996 HKSE:02496 HKSE:02181 HKSE:03681 HKSE:06978 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
77V:Germany
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Website
https://www.jacobiopharma.com
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Qiming Corporate Gp Vi, Ltd. 2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p. 2101 Beneficial owner
Qiming Gp Vi, L.p. 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Spr-iii Holdings Limited 2101 Beneficial owner
Shen Zhu 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Treasure Partner International Limited 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other

Jacobio Pharmaceuticals Group Co Headlines

No Headlines